Back
Oragenics 10K Form
Sell
46
OGEN
Oragenics
Last Price:
1.40
Seasonality Move:
20.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-03-04 | 10K | OGEN/Oragenics Annual |
| 2019-11-14 | 10Q | OGEN/Oragenics Quarterly |
| 2019-08-14 | 10Q | OGEN/Oragenics Quarterly |
| 2019-05-13 | 10Q | OGEN/Oragenics Quarterly |
| 2019-04-29 | 10K | OGEN/Oragenics Annual |
| 2019-03-29 | 10K | OGEN/Oragenics Annual |
Receive OGEN News And Ratings
See the #1 stock for the next 7 days that we like better than OGEN
OGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $131.52K |
|---|---|
| Cash Flow: | $-1.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.51 |
| Price / Book: | 3.44 |
Profitability
| EPS (TTM): | -9.25000 |
|---|---|
| Net Income (TTM): | $-20.66M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Oragenics Earnings Forecast
Key Oragenics Financial Ratios
- The Selling, General & Administrative Expenses for OGEN have been equal to 3,406.03% of Gross Profit Margin.
- The Interest Expense is -0.15% of Operating Income.
- Per Share Earnings over the last 21 years have been positive in 15 years.
Oragenics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | OGEN |
| CUSIP: | 684023 |
| Website: | oragenics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |